New real-time PCR-based method for the joint genotyping of JAK2 (V617F) with inherited thrombophilic F5 and F2 mutations

Clin Chim Acta. 2009 Dec;410(1-2):59-63. doi: 10.1016/j.cca.2009.09.022. Epub 2009 Sep 22.

Abstract

Background: During the last years the appearance of the acquired V617F mutation of the Janus Kinase 2 gene (JAK2) in patients suffering different thrombotic events has been described. We decided to develop a new and rapid multiplex real-time Polymerase Chain Reaction (PCR) in order to detect the V617F mutation together with the inherited prothrombotic mutations of factors F5 and F2.

Design and methods: The method was carried out on the LightCycler 2.0 (Roche Diagnostics, Mannheim, Germany) and consisted in a first step of simultaneous amplification by real-time PCR of the three genes to be genotyped, in a 20microl closed tube, using a primer pair together with the correspondent FRET-hybridization probes for each gene.

Results: We assayed 41 samples in the multiplex PCR reaction, 19 were positive (46.34%) for V617F mutation. From the V617F positive samples we found 1 sample heterozygous for F2 (5.26%) and 1 sample heterozygous for F5 (5.26%), so a 10.52% of the samples tested combine V617F mutation with inherited thrombophilic mutations. Results were clear, rapid and reliable allowing a significant time saving.

Conclusions: The technique presented in this manuscript is a new achievement in the field of the molecular diagnosis that combines the genotyping of F5 and F2 with the assessment of the JAK2 (V617F) mutation load.

Publication types

  • Evaluation Study

MeSH terms

  • DNA Primers
  • Factor V / genetics*
  • Gene Frequency
  • Genotype
  • Humans
  • Janus Kinase 2 / genetics*
  • Methods
  • Mutation, Missense
  • Polymerase Chain Reaction / methods*
  • Prothrombin / genetics*
  • Retrospective Studies
  • Thrombophilia / genetics*

Substances

  • DNA Primers
  • Factor V
  • Prothrombin
  • Janus Kinase 2